Michael Konkel
6Patents
2h-index
12Co-inventors
44Inventor score
Filing activity: Jan 17, 2001 → Jan 10, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7081470B2 | Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods | Chemistry; Metallurgy | 5 | Expired |
| US7166635B2 | 3-imino-2-indolones for the treatment of depression and/or anxiety | Chemistry; Metallurgy | 3 | Expired |
| US7465750B2 | Use of GAL3 antagonist for treatment of depression and/or anxiety and compounds useful in such methods | Chemistry; Metallurgy | 1 | Active |
| US8198313B2 | Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods | Chemistry; Metallurgy | 0 | Active |
| US6706716B2 | Compounds specific for the human &agr;1d adrenergic receptor and uses thereof | Human Necessities | 0 | Expired |
| US7868034B2 | Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.